Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
4.210
+0.090 (2.18%)
At close: Jun 26, 2026, 4:00 PM EDT
4.190
-0.020 (-0.48%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Adagene Employees
Adagene had 128 employees as of December 31, 2025. The number of employees decreased by 10 or -7.25% compared to the previous year.
Employees
128
Change (1Y)
-10
Growth (1Y)
-7.25%
Revenue / Employee
$59,929
Profits / Employee
-$137,574
Market Cap
276.84M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Invivyd | 122 |
| Niagen Bioscience | 117 |
| Zentalis Pharmaceuticals | 106 |
| Neumora Therapeutics | 92 |
| Cartesian Therapeutics | 75 |
| InflaRx | 65 |
| Surrozen | 44 |
ADAG News
- 5 weeks ago - Adagene Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 5 weeks ago - Adagene Slides: Investor presentation - Filings
- 6 weeks ago - Adagene to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Adagene presents data from two Phase 1b/2 studies of muzastotug at AACR - TheFly
- 2 months ago - Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug's Potential as a Backbone Combination Therapy for Multiple Tumor Types - GlobeNewsWire
- 2 months ago - Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board - GlobeNewsWire
- 2 months ago - Adagene price target raised to $10 from $9 at Guggenheim - TheFly
- 3 months ago - Adagene Slides: Investor presentation - Filings